
October 9–11, 2025 | Bloomington, Minnesota
Overview
The Neurology Residents Scholar Program (NRSP) is designed for second- and third year neurology residents and child neurology fellows as an additional opportunity in epilepsy education. The NRSP is an intensive multi-day course that addresses all clinical aspects of epilepsy, including the latest developments in diagnosis and treatment. Founded by the late Dr. John Gates of the Minnesota Epilepsy Group, PA, the NRSP is in its 23rd year of educating residents and fellows about epilepsy to improve patient care. The curriculum is intended to augment general neurology residency programs. With epilepsy presenting in a third of adult neurological disorders and more than two-thirds of pediatric neurological cases, there is a definitive need to better inform general neurologists and child neurologists about this condition.
For questions, please contact Ashley Lilly, Account Director, at lillya@ceconcepts.com
Travel
Each participant will receive a $400 travel scholarship on-site at NRSP 2025.
- Attendees will be responsible for their airfare to and from Minnesota
- Attendees will be responsible for hotel rooms at $139 + tax per night (attendees will be responsible for reserving a room and paying on site; a dedicated link will be sent to selected residents/fellows)
Who Should Attend
Neurology residents/fellows who are nominated to attend the NRSP are selected by their program directors. Ideal candidates for the program are in their second or third year of residency, and are committed to improving their diagnostic skills and furthering their knowledge of the treatment of epilepsy. During this multi-day meeting, residents/fellows attend interactive lectures and participate in breakout workshops in which they discuss clinical cases with colleagues from across the United States. Each resident/fellow is required to prepare and present one brief case study on an epilepsy-related topic of their choice.
Case Study
All registrants are required to present a seizure-related clinical case during their assigned case study breakout session. All case study presentations must be submitted in advance in PowerPoint format and include EEG tracings. The presentation should total no more than 6–8 slides, with the expectation of approximately 10 minutes for both presentation and discussion. Case study submission requirements will be emailed to residents/fellows following registration.
Learning Objectives
- Differentiate seizure and epilepsy types inclusive of International League Against Epilepsy (ILAE) classifications that reflect underlying mechanisms
- Accurately assess and characterize epilepsy according to seizure etiology, age of onset, risk factors, and other relevant factors
- Integrate genetic testing as recommended for the diagnosis and assessment of epilepsy
- Evaluate the challenges and limitations associated with traditional anti-epilepsy drugs (AEDs)
- Evaluate newer and emerging pharmacotherapies including how these agents may be integrated into individualized epilepsy treatment plans
- Identify the role of nonpharmacologic approaches in the improvement of health outcomes among those with treatment-resistant epilepsy
- Utilize strategies designed to optimize adherence to AEDs
- Engage in patient/caregiver education and shared decision-making (SDM) to improve patient engagement, adherence, and satisfaction with epilepsy care
- Incorporate strategies to address treatment barriers related to disparities that affect health care access and quality, and therapeutic success
Target Audience
PGY-2 and PGY-3 neurology residents and child neurology fellows completing training at an ACGME-accredited U.S. training program

Accreditation
In support of improving patient care, Creative Educational Concepts LLC (CEC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
ACCME (Physician): CEC designates this live educational activity for a maximum of 10 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Upon completion of a CE request form, statements of credit for physicians will be issued within 30 business days via email.
Tentative Agenda
THURSDAY, OCTOBER 9, 2025
11:30 AM–12:30 PM |
Registration |
12:30 PM–1:00 PM |
Boxed Lunch/Ice Breaker |
1:00 PM–5:30 PM |
Educational Sessions |
6:00 PM–7:00 PM |
Welcome Dinner/Reception |
FRIDAY, OCTOBER 10, 2025
7:30 AM–8:00 AM |
Buffet Breakfast |
8:00 AM–12:00 PM |
Educational Sessions |
12:00 PM–1:00 PM |
Lunch |
1:00 PM–5:45 PM |
Educational Sessions |
6:00 PM–7:30 PM |
Dinner: Meet-the-Faculty—Paving a Path to Epilepsy Practice |
SATURDAY, OCTOBER 11, 2025
7:30 AM–8:00 AM |
Buffet Breakfast |
8:00 AM–11:15 AM |
Educational Sessions |
11:15 AM–11:30 AM |
Post-test/Closing Remarks/Q&A Session |
11:30 AM |
Grab-and-Go Lunch/Departures |
*AMA PRA Category 1 Accredited Session
Faculty

Patricia E. Penovich, MD (Co-Chair)
Adjunct Clinical Professor, University of Minnesota
Emeritus, Minnesota Epilepsy Group PA
St. Paul, Minnesota

David Spencer, MD (Co-Chair)
Professor of Neurology
Director, OHSU Epilepsy Program
Oregon Health & Science University
Portland, Oregon
Invited Faculty



Heidi Currier, MD, FANA, FAES, FAAN
Minnesota Epilepsy Group
St. Paul, MN
Jason Little, MD
Mayo Clinic
Rochester, MN
Andres M. Kanner, MD, FAAN
University of Miami, Miller School of Medicine
Miami, FL

Michael C. Smith, MD
Rush Epilepsy Center
Chicago, IL

Elizabeth A. Thiele, MD, PhD
Harvard Medical School
Boston, MA

Douglas Smith, MD
Minnesota Epilepsy Group
St. Paul, MN
Presented by Creative Educational Concepts, LLC.
2025 Educational Supporters
Jazz Pharmaceuticals, LivaNova, Neurelis, and UCB Inc.